Tu; Meihua Mike
Patent Applications and Registrations
Patent applications and USPTO patent grants for Tu; Meihua Mike.The latest application filed is for "(aza)benzothiazolyl substituted pyrazole compounds".
- Tu; Meihua Mike - Acton MA
- Tu; Meihua Mike - Mystic CT US
| Patent | Date |
|---|---|
| (AZA)Benzothiazolyl Substituted Pyrazole Compounds App 20220184041 - Cabral; Shawn ; et al. | 2022-06-16 |
| Glucagon Receptor Modulators App 20160362392 - Aspnes; Gary Erik ; et al. | 2016-12-15 |
| Glucagon receptor modulators Grant 9,452,999 - Aspnes , et al. September 27, 2 | 2016-09-27 |
| Indole and indazole compounds that activate AMPK Grant 9,394,285 - Bhattacharya , et al. July 19, 2 | 2016-07-19 |
| Indole and Indazole Compounds that Activate AMPK App 20160016940 - Bhattacharya; Samit Kumar ; et al. | 2016-01-21 |
| Glucagon Receptor Modulators App 20150266861 - Aspnes; Gary Erik ; et al. | 2015-09-24 |
| Glucagon Receptor Modulators App 20150266859 - Aspnes; Gary Erik ; et al. | 2015-09-24 |
| Glucagon receptor modulators Grant 9,073,871 - Aspnes , et al. July 7, 2 | 2015-07-07 |
| Glucagon receptor modulators Grant 9,056,834 - Aspnes , et al. June 16, 2 | 2015-06-16 |
| Glucagon Receptor Modulators App 20150094338 - Aspnes; Gary Erik ; et al. | 2015-04-02 |
| Glucagon receptor modulators Grant 8,933,104 - Aspnes , et al. January 13, 2 | 2015-01-13 |
| Glucagon Receptor Modulators App 20140371467 - Aspnes; Gary Erik ; et al. | 2014-12-18 |
| Glucagon Receptor Modulators App 20140329862 - Aspnes; Gary Erik ; et al. | 2014-11-06 |
| Glucagon receptor modulators Grant 8,859,591 - Aspnes , et al. October 14, 2 | 2014-10-14 |
| Glucagon receptor modulators Grant 8,809,342 - Aspnes , et al. August 19, 2 | 2014-08-19 |
| Glucagon Receptor Modulators App 20130296355 - Aspnes; Gary Erik ; et al. | 2013-11-07 |
| Glucagon receptor modulators Grant 8,507,533 - Aspnes , et al. August 13, 2 | 2013-08-13 |
| Substituted Heteroaryls App 20130165452 - Benbow; John William ; et al. | 2013-06-27 |
| (S)-6-(2-(4-(cyclobutylsulfonyl)-1H-imidazol-1-yl)-3-cyclopentylpropanamid- o)nicotinic acid useful as a glucokinase activator Grant 8,389,552 - Pfefferkorn , et al. March 5, 2 | 2013-03-05 |
| Substituted imidazoles useful for treating type II diabetes Grant 8,329,920 - Benbow , et al. December 11, 2 | 2012-12-11 |
| Substituted Heteroaryls App 20120225910 - Pfefferkorn; Jeffrey Allen ; et al. | 2012-09-06 |
| Glucagon Receptor Modulators App 20120202834 - Aspnes; Gary Erik ; et al. | 2012-08-09 |
| Glucagon Receptor Modulators App 20120165343 - Aspnes; Gary Erik ; et al. | 2012-06-28 |
| Substituted Heteroaryls App 20110230445 - Benbow; John William ; et al. | 2011-09-22 |
| Substituted imidazole propanamide glucokinase activators Grant 7,977,367 - Benbow , et al. July 12, 2 | 2011-07-12 |
| Substituted Heteroaryls App 20100063063 - Benbow; John William ; et al. | 2010-03-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 